Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty.

Malaria Journal
David L SmithRamanan Laxminarayan

Abstract

The evolution of drug resistance in malaria parasites highlights a need to identify and evaluate strategies that could extend the useful therapeutic life of anti-malarial drugs. Such strategies are deployed to best effect before resistance has emerged, under conditions of great uncertainty. Here, the emergence and spread of resistance was modelled using a hybrid framework to evaluate prospective strategies, estimate the time to drug failure, and weigh uncertainty. The waiting time to appearance was estimated as the product of low mutation rates, drug pressure, and parasite population sizes during treatment. Stochastic persistence and the waiting time to establishment were simulated as an evolving branching process. The subsequent spread of resistance was simulated in simple epidemiological models. Using this framework, the waiting time to the failure of artemisinin combination therapy (ACT) for malaria was estimated, and a policy of multiple first-line therapies (MFTs) was evaluated. The models quantify the effects of reducing drug pressure in delaying appearance, reducing the chances of establishment, and slowing spread. By using two first-line therapies in a population, it is possible to reduce drug pressure while still treat...Continue Reading

References

Oct 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·S BonhoefferB R Levin
Jun 12, 1999·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·N White
Oct 6, 1999·Current Opinion in Microbiology·D I Andersson, B R Levin
Jun 8, 2001·Parasitology·S Paget-McNicol, A Saul
Jan 5, 2002·Trends in Parasitology·R W SnowK Marsh
Jun 7, 2003·The Journal of Infectious Diseases·James G KublinChristopher V Plowe
Dec 12, 2003·Nature·Rustom AntiaCarl T Bergstrom
Jan 10, 2006·PLoS Medicine·Kevin R Foster, Hajo Grundmann
May 2, 2006·Advances in Parasitology·C A GuerraS I Hay
Aug 8, 2006·Current Opinion in Microbiology·Dan I Andersson
Oct 17, 2006·PLoS Computational Biology·Andreas HandelRustom Antia
Nov 10, 2006·The New England Journal of Medicine·Miriam K LauferChristopher V Plowe
Nov 1, 1943·Genetics·S E Luria, M Delbrück
Apr 19, 2008·Science·N J White
Sep 11, 2008·Proceedings of the National Academy of Sciences of the United States of America·Maciej F BoniRamanan Laxminarayan
Feb 20, 2009·Malaria Journal·Nicholas J White
Mar 28, 2009·PLoS Medicine·Simon I HayRobert W Snow
Jul 15, 2009·Health Affairs·Ramanan Laxminarayan, Hellen Gelband
Jul 31, 2009·The New England Journal of Medicine·Harald NoedlWichai Satimai
Oct 30, 2009·Trends in Parasitology·Ananias A EscalanteYuseob Kim
Jun 22, 2010·PLoS Medicine·Simon I HayRobert W Snow

❮ Previous
Next ❯

Citations

Aug 24, 2012·Malaria Journal·Xavier C DingTimothy N C Wells
Jun 21, 2013·Malaria Journal·David Ubben, Elizabeth M Poll
Dec 19, 2013·PLoS Computational Biology·T Alex PerkinsDavid L Smith
Nov 8, 2015·The Lancet Global Health·Tran Dang NguyenMaciej F Boni
Nov 8, 2015·The Lancet Global Health·George Jagoe, John H Amuasi
Apr 15, 2016·Journal of the Royal Society, Interface·Mathieu Legros, Sebastian Bonhoeffer
Dec 1, 2012·International Journal for Parasitology. Drugs and Drug Resistance·Carol Hopkins Sibley, Ric N Price
Jan 17, 2012·Veterinary Parasitology·David J BartramSteven J Maeder
Oct 30, 2016·Trends in Parasitology·Hannah C SlaterAzra C Ghani
Apr 22, 2015·The American Journal of Tropical Medicine and Hygiene·John P RenschlerRamanan Laxminarayan
Oct 3, 2017·Expert Review of Clinical Pharmacology·Jane AchanUmberto D'alessandro
Dec 1, 2017·PLoS Medicine·UNKNOWN malERA Refresh Consultative Panel on Insecticide and Drug Resistance
Aug 22, 2018·PLoS Biology·Mary BushmanJacobus C de Roode
Jul 26, 2019·Computational and Mathematical Methods in Medicine·Titus Okello OrwaLivingstone Serwadda Luboobi
Apr 11, 2018·Evolutionary Applications·Silvie Huijben, Krijn P Paaijmans
Feb 29, 2020·Journal of Clinical Pharmacology·Juntra Karbwang, Kesara Na-Bangchang
Aug 6, 2021·Expert Review of Anti-infective Therapy·Charlotte RasmussenPascal Ringwald

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Maciej F BoniRamanan Laxminarayan
The Lancet Infectious Diseases
Chansuda WongsrichanalaiSteven R Meshnick
© 2021 Meta ULC. All rights reserved